Enhancing the electrochromic characteristics of conjugated polymer with TiO2 nano‐rods

Organic soluble, oleic acid capped TiO₂ nano‐rod was well‐mixed with the electrochromic polymer: Poly‐(4,4‐dioctylcyclopenta[2,1‐b:3,4‐b′]‐dithiophene (PDOCPDT) to form TiO₂/PDOCPDT nanocompsoite. TiO₂/PDOCPDT film showed high electrochemical stability and its coloration efficiency is 1.5 times of that for pure PDOCPDT. The function of TiO₂ nano‐rods can be regarded as a dispersion agent. PDOCPDT chains in TiO₂/PDOCPDT may have a less aggregated structure and more open morphology, therefore has higher coloration efficiency. TiO₂ may also act as electron transport or temporary electron storage centers, electrons can be transferred reversibly between PDOCPDT and TiO₂ nano‐rods. TiO₂/PDOCPDT is well‐soluble in CHCl₃, large area thin films can be fabricated reproducibly simply by spin coating. © 2008 Wiley Periodicals, Inc. J Polym Sci Part B: Polym Phys 46: 1121–1130, 2008     

Selection of aptamers for signal transduction proteins by capillary electrophoresis

High‐affinity aptamers for important signal transduction proteins, i.e. Cdc42‐GTP, p21‐activated kinase1 (PAK1) and MRCK (myotonic dystrophy kinase‐related Cdc42‐binding kinase) α were successfully selected in the low micro‐ to nanomolar range using non‐systematic evolution of ligands by exponential enrichment (SELEX) with at least three orders of magnitude enhancement from their respective bulk affinity of naïve DNA library. In the non‐SELEX procedure, CE was used as a highly efficient affinity method to select aptamers for the desired molecular target through a process that involved repetitive steps of partitioning, known as non‐equilibrium CE of equilibrium mixtures with no PCR amplification between successive steps. Various non‐SELEX conditions including the type, concentration and pH of the run buffer were optimized. Other considerations such as salt composition of selection buffer, protein concentration and sample injection size were also studied for high stringency during selection. After identifying the best enriched aptamer pool, randomly selected clones from the aptamer pool were sequenced to obtain the individual DNA sequences. The dissociation constants (K_d) of these sequences were in the low micromolar to nanomolar range, indicating high affinity to the respective proteins. The best binders were also subjected to sequence alignment to generate a phylogenetic tree. No significant consensus region based on approximately 50 sequences for each protein was observed, suggesting the high efficiency of non‐SELEX for the selection of numerous unique sequences with high selectivity.     

Ueber Glykosid- und alkaloidartige Reactionen

Ohne Zusammenfassung     

Ueber die mikroskopische Erkennung des Mutterkorns

Ohne Zusammenfassung     

Cisplatin cyclodextrin complexes as potential free radical chemoradiosensitizers for enhanced cisplatin treatment of cancers: a quantum mechanical study

It has been shown in this study that {CisPt@[n]CD} complexes formed from the anti-cancer drug cisplatin (CisPt) and cyclodextrins ([n]CD) can be a source of Pt based free radicals such as (H₃N)₂PtCl· and (H₃N)₂Pt·· species in water within a radiation environment which can produce hydrated electrons. Encapsulating CisPt within the [n]CD host takes advantage of the previously described drug delivery and reduced side effect advantages of CDs. Based on quantum mechanical modelling and literature results from other studies, it is predicted that {CisPt@[γ]CD} and the analogous 2-hydroxypropyl[β]cyclodextrin (HPBCD) complex {CisPt@HPBCD} may interact with serum albumin and engage in an enhanced permeation and retention mechanism in solid tumours, offering further synergistic advantages for radiation-{CisPt@[γ]CD} or -{CisPt@HPBCD} regimens over that of the conventional radiation-CisPt regimens in current use in anti-cancer chemoradiotherapies. Comparisons and possible advantages are made with the previously documented chemoradiosensitizing properties of the analogous cucurbit[7]uril based{CisPt@[7]CB} complex with the {CisPt@[γ]CD} and {CisPt@HPBCD} complexes suggest that all three complexes may have different and tailorable anti-tumour uses for a range of different chemotherapeutic environments or protocols.